{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:31:06Z","timestamp":1790674266013,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":265,"publisher":"Springer Singapore","isbn-type":[{"value":"9789813297203","type":"print"},{"value":"9789813297210","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-32-9721-0_3","type":"book-chapter","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T22:02:48Z","timestamp":1573250568000},"page":"27-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Genetic Markers of Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Matea","family":"Nikolac Perkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nela","family":"Pivac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,10]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2012.00073","volume":"3","author":"J Cerejeira","year":"2012","unstructured":"Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73.","journal-title":"Front Neurol."},{"issue":"6","key":"3_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.21037\/atm.2016.03.05","volume":"4","author":"Christiane Reitz","year":"2016","unstructured":"Reitz C (2016) Toward precision medicine in Alzheimer\u2019s disease. Ann Transl Med. 2016;4(6):107.","journal-title":"Annals of Translational Medicine"},{"issue":"2","key":"3_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/13697137.2017.1287866","volume":"20","author":"H Hampel","year":"2017","unstructured":"Hampel H, O\u2019Bryant S, Durrleman S, Younesi E, Rojkova K, Escott-Price V, et al. A precision medicine Initiative for Alzheimer\u2019s disease: the road ahead to biomarker-guided integrative disease modeling. Climacteric. 2017;20(2):107\u201318.","journal-title":"Climacteric"},{"issue":"5","key":"3_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1567205015666171212094229","volume":"15","author":"M Nikolac Perkovic","year":"2018","unstructured":"Nikolac Perkovic M, Svob Strac D, Tudor L, Konjevod M, Nedic Erjavec G, Pivac N. Catechol-O-methyltransferase, cognition and Alzheimer\u2019s disease. Curr Alzheimer Res. 2018;15(5):408\u201319.","journal-title":"Curr Alzheimer Res"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuropharm.2018.01.044","volume":"136","author":"A.I. Duarte","year":"2018","unstructured":"Duarte A, Santos MS, Oliveira CR. Moreira P. Brain insulin signalling, glucose metabolism and females\u2019 reproductive aging: a dangerous triad in Alzheimer\u2019s disease. Neuropharmacology. 2018;136(Pt B):223\u201342.","journal-title":"Neuropharmacology"},{"issue":"5","key":"3_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Cauwenberghe Van","year":"2015","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2015;18(5):421\u201330.","journal-title":"Genet Med"},{"issue":"5226","key":"3_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science. 1995;269(5226):973\u20137.","journal-title":"Science"},{"issue":"22","key":"3_CR8","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1101\/gad.836900","volume":"14","author":"R Kopan","year":"2000","unstructured":"Kopan R, Goate A. A common enzyme connects Notch signaling and Alzheimer\u2019s disease. Genes Dev. 2000;14(22):2799\u2013806.","journal-title":"Genes Dev"},{"issue":"8","key":"3_CR9","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/emboj\/21.8.1948","volume":"21","author":"P Marambaud","year":"2002","unstructured":"Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, et al. A presenilin-1\/\u03b3-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 2002;21(8):1948\u201356.","journal-title":"EMBO J"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"27303","DOI":"10.1074\/jbc.M413969200","volume":"280","author":"A Lle\u00f3","year":"2005","unstructured":"Lle\u00f3 A, Waldron E, von Arnim CA, Herl L, Tangredi MM, Peltan ID, et al. Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase. J Biol Chem. 2005;280:27303\u20139.","journal-title":"J Biol Chem"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"19777","DOI":"10.1074\/jbc.M412457200","volume":"280","author":"GA Vidal","year":"2005","unstructured":"Vidal GA, Naresh A, Marrero L, Jones FE. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4\/HER4 activities. J Biol Chem. 2005;280:19777\u201383.","journal-title":"J Biol Chem"},{"issue":"19","key":"3_CR12","first-page":"15132","volume":"9","author":"MH Dai","year":"2017","unstructured":"Dai MH, Zheng H, Zeng LD, Zhang Y. The genes associated with early-onset Alzheimer\u2019s disease. Oncotarget. 2017;9(19):15132\u201343.","journal-title":"Oncotarget"},{"issue":"2","key":"3_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ajhg.2011.07.011","volume":"89","author":"M Larsson","year":"2011","unstructured":"Larsson M, Duffy DL, Zhu G, Liu JZ, Macgregor S, McRae AF, et al. GWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern development. Am J Hum Genet. 2011;89(2):334\u201343.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"3_CR14","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"e114777","DOI":"10.1371\/journal.pone.0114777","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Yu JT, Wang HF, Hao XK, Yang YF, Jiang T, et al. Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer\u2019s disease. PLoS ONE. 2014;9:e114777.","journal-title":"PLoS ONE"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1038\/tp.2014.2","volume":"4","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Heilmann S, Becker T, Hern\u00e1ndez I, Wagner H, Thelen M, et al. Follow-up of loci from the International Genomics of Alzheimer\u2019s Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry. 2014;4:e358.","journal-title":"Transl Psychiatry"},{"issue":"4","key":"3_CR17","doi-asserted-by":"publisher","first-page":"e95152","DOI":"10.1371\/journal.pone.0095152","volume":"9","author":"SL Rosenthal","year":"2014","unstructured":"Rosenthal SL, Barmada MM, Wang X, Demirci FY, Kamboh MI. Connecting the dots: potential of data integration to identify regulatory SNPs in late-onset Alzheimer\u2019s disease GWAS findings. PLoS ONE. 2014;9(4):e95152.","journal-title":"PLoS ONE"},{"issue":"2","key":"3_CR18","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1212\/NXG.0000000000000012","volume":"1","author":"M Allen","year":"2015","unstructured":"Allen M, Kachadoorian M, Carrasquillo MM, Karhade A, Manly L, Burgess JD, et al. Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurol Genet. 2015;1(2):e15.","journal-title":"Neurol Genet"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"e0144898","DOI":"10.1371\/journal.pone.0144898","volume":"10","author":"B Jiao","year":"2015","unstructured":"Jiao B, Liu X, Zhou L. Polygenic analysis of late-onset Alzheimer\u2019s disease from mainland China. PLoS ONE. 2015;10:e0144898.","journal-title":"PLoS ONE"},{"issue":"9","key":"3_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66(9):616\u201323.","journal-title":"IUBMB Life"},{"issue":"3","key":"3_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.nbd.2005.12.016","volume":"22","author":"MK Lai","year":"2006","unstructured":"Lai MK, Tsang SW, Garcia-Alloza M, Minger SL, Nicoll JA, Esiri MM, et al. Selective effects of the APOE \u03b54 allele on presynaptic cholinergic markers in the neocortex of Alzheimer\u2019s disease. Neurobiol Dis. 2006;22(3):555\u201361.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180\u20134.","journal-title":"Nat Genet"},{"issue":"11","key":"3_CR23","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1212\/01.WNL.0000128091.92139.0F","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 2004;62(11):1977\u201383.","journal-title":"Neurology"},{"issue":"3","key":"3_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000320136","volume":"30","author":"Y Liu","year":"2010","unstructured":"Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund LO, Simmons A, et al. APOE \u03b52 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord. 2010;30(3):229\u201337.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"12","key":"3_CR25","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. ApoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118(12):4002\u201313.","journal-title":"J Clin Invest"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"41235","DOI":"10.1038\/srep41235","volume":"7","author":"SR Matukumalli","year":"2017","unstructured":"Matukumalli SR, Tangirala R, Rao CM. Clusterin: full-length protein and one of its chains show opposing effects on cellular lipid accumulation. Sci Reports. 2017;7:41235.","journal-title":"Sci Reports"},{"issue":"1","key":"3_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12264-013-1391-2","volume":"30","author":"X Li","year":"2014","unstructured":"Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J, Zhao Z. Clusterin in Alzheimer\u2019s disease: a player in the biological behaviour of amyloid-beta. Neurosci Bull. 2014;30(1):162\u20138.","journal-title":"Neurosci Bull"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/0024-3205(96)00310-4","volume":"59","author":"BV Zlokovic","year":"1996","unstructured":"Zlokovic BV. Cerebrovascular transport of Alzheimer\u2019s amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci. 1996;59:1483\u201397.","journal-title":"Life Sci"},{"issue":"10","key":"3_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1088\u201393.","journal-title":"Nat Genet"},{"issue":"10","key":"3_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR29 associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1094\u20139.","journal-title":"Nat Genet"},{"issue":"7","key":"3_CR31","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/tp.2011.17","volume":"1","author":"M Szymanski","year":"2011","unstructured":"Szymanski M, Wang R, Bassett SS, Avramopoulos D. Alzheimer\u2019s risk variants in the clusterin gene are associated with alternative splicing. Transl Psychiatry. 2011;1(7):e18.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"3_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1326-7-3","volume":"16","author":"K Bettens","year":"2012","unstructured":"Bettens K, Brouwers N, Engelborghs S, Lambert JC, Rogaeva E, Vandenberghe R, et al. Both common variations and rare non-synonymous substitutions and small insertion\/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener. 2012;16(7):3.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"3_CR33","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1523\/JNEUROSCI.4946-05.2006","volume":"26","author":"K Offe","year":"2006","unstructured":"Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, et al. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci. 2006;26(5):1596\u2013603.","journal-title":"J Neurosci"},{"issue":"2","key":"3_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007;39(2):168\u201377.","journal-title":"Nat Genet"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.24305","volume":"77","author":"BN Vardarajan","year":"2015","unstructured":"Vardarajan BN, Zhang Y, Lee JH, Cheng R, Bohm C, Ghani M, et al. Coding mutations in SORL1 and Alzheimer disease. Ann Neurol. 2015;77:215\u201327.","journal-title":"Ann Neurol"},{"issue":"4","key":"3_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","volume":"16","author":"JE Young","year":"2015","unstructured":"Young JE, Boulanger-Weill J, Williams DA, Woodruff G, Buen F, Revilla AC, et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell. 2015;16(4):373\u201385.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43(5):429\u201335.","journal-title":"Nat Genet"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2013.09.058","volume":"556","author":"JB Vasquez","year":"2013","unstructured":"Vasquez JB, Fardo DW, Estus S. ABCA7 expression is associated with Alzheimer\u2019s disease polymorphism and disease status. Neurosci Lett. 2013;556:58\u201362.","journal-title":"Neurosci Lett"},{"issue":"5","key":"3_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, Stefansson H, Jonsson T, Johannsdottir H, Ingason A, Helgason H, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet. 2015;47(5):445\u20137.","journal-title":"Nat Genet"},{"issue":"18","key":"3_CR40","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832\u201340.","journal-title":"JAMA"},{"issue":"11","key":"3_CR41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013;18(11):1225\u201334.","journal-title":"Mol Psychiatry"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","volume":"287","author":"Q Xiao","year":"2012","unstructured":"Xiao Q, Gil SC, Yan P, Wang Y, Han S, Gonzales E, et al. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem. 2012;287:21279\u201389.","journal-title":"J Biol Chem"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, et al. Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat Neurosci. 2015;18:978\u201387.","journal-title":"Nat Neurosci"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1038\/ncomms5998","volume":"5","author":"K Moreau","year":"2014","unstructured":"Moreau K, Fleming A, Imarisio S, Lopez Ramirez A, Mercer JL, Jimenez-Sanchez M, et al. PICALM modulates autophagy activity and tau accumulation. Nat Commun. 2014;5:4998.","journal-title":"Nat Commun"},{"issue":"2","key":"3_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/mp.2011.24","volume":"17","author":"N Brouwers","year":"2012","unstructured":"Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites. Mol Psychiatry. 2012;17(2):223\u201333.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"3_CR46","doi-asserted-by":"publisher","first-page":"2949.e5","DOI":"10.1016\/j.neurobiolaging.2012.07.001","volume":"33","author":"LN Hazrati","year":"2012","unstructured":"Hazrati LN, Van Cauwenberghe C, Brooks PL, Brouwers N, Ghani M, Sato C, et al. Genetic association of CR45 with Alzheimer\u2019s disease: a tentative disease mechanism. Neurobiol Aging. 2012;33(12):2949.e5\u201312.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"3_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet. 2011;43(5):436\u201341.","journal-title":"Nat Genet"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS ONE. 2012;7:e50976.","journal-title":"PLoS ONE"},{"issue":"4","key":"3_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631\u201343.","journal-title":"Neuron"},{"issue":"7","key":"3_CR50","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16(7):848\u201350.","journal-title":"Nat Neurosci"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fimmu.2013.00195","volume":"4","author":"J Zuccolo","year":"2013","unstructured":"Zuccolo J, Deng L, Unruh TL, Sanyal R, Bau JA, Storek J, et al. Expression of MS4A and TMEM176 genes in human B lymphocytes. Front Immunol. 2013;4:195.","journal-title":"Front Immunol"},{"key":"3_CR52","doi-asserted-by":"publisher","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, et al. The MS4A gene cluster is a key regulator of soluble TREM2 and Alzheimer disease risk. BioRxiv. 2018. https:\/\/doi.org\/10.1101\/352179 .","DOI":"10.1101\/352179"},{"issue":"5","key":"3_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/gm249","volume":"3","author":"C Antunez","year":"2011","unstructured":"Antunez C, Boada M, Gonz\u00e1lez-P\u00e9rez A, Gay\u00e1n J, Ram\u00edrez-Lorca R, Mar\u00edn J, et al. The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer\u2019s disease. Genome Med. 2011;3(5):33.","journal-title":"Genome Med."},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich JD, Ulland TK, Colonna M, Holtzman DM. Elucidating the Role of TREM2 in Alzheimer\u2019s disease. Neuron. 2017;94:237\u201348.","journal-title":"Neuron"},{"issue":"9","key":"3_CR55","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamaneurol.2013.2815","volume":"70","author":"JM Shulman","year":"2013","unstructured":"Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, et al. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013;70(9):1150\u20137.","journal-title":"JAMA Neurol"},{"issue":"16","key":"3_CR56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"L. A. Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"16","key":"3_CR57","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0b013e3182515972","volume":"78","author":"BV Hooli","year":"2012","unstructured":"Hooli BV, Mohapatra G, Mattheisen M, Parrado AR, Roehr JT, Shen Y, et al. Role of common and rare APP DNA sequence variants in Alzheimer disease. Neurology. 2012;78(16):1250\u20137.","journal-title":"Neurology"},{"issue":"9","key":"3_CR58","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/jnnp.2008.161703","volume":"80","author":"K Kasuga","year":"2009","unstructured":"Kasuga K, Shimohata T, Nishimura A, Shiga A, Mizuguchi T, Tokunaga J, et al. Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80(9):1050\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3_CR59","doi-asserted-by":"publisher","first-page":"426.e13","DOI":"10.1016\/j.neurobiolaging.2010.10.010","volume":"33","author":"D McNaughton","year":"2012","unstructured":"McNaughton D, Knight W, Guerreiro R, Ryan N, Lowe J, Poulter M, et al. Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging. 2012;33(2):426.e13\u201321.","journal-title":"Neurobiol Aging"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/1756-0500-4-476","volume":"4","author":"H Thonberg","year":"2011","unstructured":"Thonberg H, Fallstr\u00f6m M, Bj\u00f6rkstr\u00f6m J, Schoumans J, Nennesmo I, Graff C. Mutation screening of patients with Alzheimer disease identifies APP locus duplication in a Swedish patient. BMC Res Notes. 2011;4:476.","journal-title":"BMC Res Notes"},{"issue":"4","key":"3_CR61","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-2012-120172","volume":"30","author":"D Wallon","year":"2012","unstructured":"Wallon D, Rousseau S, Rovelet-Lecrux A, Quillard-Muraine M, Guyant-Mar\u00e9chal L, Martinaud O, et al. The French series of autosomal dominant early onset Alzheimer\u2019s disease cases: mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis. 2012;30(4):847\u201356.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"3_CR62","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/07853890802186905","volume":"40","author":"N Brouwers","year":"2008","unstructured":"Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer\u2019s disease: an update. Ann Med. 2008;40(8):562\u201383.","journal-title":"Ann Med"},{"issue":"5","key":"3_CR63","first-page":"998","volume":"51","author":"K Kamino","year":"1992","unstructured":"Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet. 1992;51(5):998\u20131014.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"3_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1(5):345\u20137.","journal-title":"Nat Genet"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0197-4580(00)82487-2","volume":"21","author":"Camilla Nilsberth","year":"2000","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Forsell C, Axelman K, Luthman J, et al. The Arctic APP mutation (E693G) causes Alzheimer\u2019s disease through a novel mechanism: increased amyloid \u03b2 protofibril formation and decreased amyloid \u03b2 levels in plasma and conditioned media. Neurobiol Aging. 2000;21 Suppl 1:S58.","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"3_CR66","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci. 2001;4(9):887\u201393.","journal-title":"Nat Neurosci"},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"T Tomiyama","year":"2008","unstructured":"Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. A new amyloid beta variant favoring oligomerization in Alzheimer\u2019s-type dementia. Ann Neurol. 2008;63:377\u201387.","journal-title":"Ann Neurol"},{"issue":"7","key":"3_CR68","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/jnnp.2003.010611","volume":"75","author":"Y Wakutani","year":"2004","unstructured":"Wakutani Y, Watanabe K, Adachi Y, Wada-Isoe K, Urakami K, Ninomiya H, et al. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2004;75(7):1039\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3_CR69","unstructured":"Wakutani Y. Gene symbol: APP. Disease: Familial Alzheimer\u2019s disease. Hum Genet. 2005;117(2\u20133):299."},{"issue":"7","key":"3_CR70","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1073\/pnas.96.7.4119","volume":"96","author":"K Ancolio","year":"1999","unstructured":"Ancolio K, Dumanchin C, Barelli H, Warter JM, Brice A, Campion D, et al. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 \u2192 Met betaAPP-770 mutation responsible for probable early-onset Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 1999;96(7):4119\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"208","key":"3_CR71","first-page":"e11","volume":"37","author":"C Blauwendraat","year":"2016","unstructured":"Blauwendraat C, Wilke C, Jansen IE, Schulte C, Sim\u00f3n-S\u00e1nchez J, Metzger FG, et al. Pilot whole-exome sequencing of a German early-onset Alzheimer\u2019s disease cohort reveals a substantial frequency of PSEN2 variants. Neurobiol Aging. 2016;37(208):e11\u20137.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"3_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0304-3940(95)12046-7","volume":"199","author":"WS Brooks","year":"1995","unstructured":"Brooks WS, Martins RN, De Voecht J, Nicholson GA, Schofield PR, Kwok JB, et al. A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer\u2019s disease. Neurosc Lett. 1995;199(3):183\u20136.","journal-title":"Neurosc Lett"},{"issue":"Pt 11","key":"3_CR73","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1093\/brain\/awl212","volume":"129","author":"N Brouwers","year":"2006","unstructured":"Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, Kamali K, et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer\u2019s disease. Brain. 2006;129(Pt 11):2984\u201391.","journal-title":"Brain"},{"issue":"8","key":"3_CR74","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jmg.33.8.661","volume":"33","author":"D Campion","year":"1996","unstructured":"Campion D, Brice A, Hannequin D, Charbonnier F, Dubois B, Martin C, et al. No founder effect in three novel Alzheimer\u2019s disease families with APP 717 Val \u2192 Ile mutation. Clerget-darpoux. French Alzheimer\u2019s Disease Study Group. J Med Genet. 1996;33(8):661\u20134.","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"3_CR75","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65(3):664\u201370.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"3_CR76","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1093\/hmg\/4.12.2373","volume":"4","author":"D Campion","year":"1995","unstructured":"Campion D, Flaman JM, Brice A, Hannequin D, Dubois B, Martin C, et al. Mutations of the presenilin I gene in families with early-onset Alzheimer\u2019s disease. Hum Mol Genet. 1995;4(12):2373\u20137.","journal-title":"Hum Mol Genet"},{"key":"3_CR77","doi-asserted-by":"crossref","unstructured":"Clarim\u00f3n J, Guerreiro R, Lle\u00f3 A, Guardia C, Blesa F, G\u00f3mez-Isla T, et al. Genetic screening in a large cohort of early-onset Alzheimer\u2019s disease patients from Spain: novel mutations in the amyloid precursor protein and presenilines. Alzheimer Dement. 2008;4 Supp 2:T583.","DOI":"10.1016\/j.jalz.2008.05.1780"},{"issue":"1S","key":"3_CR78","first-page":"S327","volume":"23","author":"M Cruts","year":"2002","unstructured":"Cruts M, Dermaut B, Kumar-Singh S, Rademakers R, Van den Broeck M, St\u00f6gbauer F, et al. Novel German APP V715A mutation associated with presenile Alzheimer\u2019s disease. Neurobiol Aging. 2002;23(1S):S327.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"3_CR79","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00415-003-0182-5","volume":"250","author":"M Cruts","year":"2003","unstructured":"Cruts M, Dermaut B, Rademakers R, Van den Broeck M, Stogbauer F, Van Broeckhoven C. Novel APP mutation V715A associated with presenile Alzheimer\u2019s disease in a German family. J Neurol. 2003;250(11):1374\u20135.","journal-title":"J Neurol"},{"issue":"1","key":"3_CR80","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1016\/S0197-4580(00)82241-1","volume":"21","author":"C Jonghe De","year":"2000","unstructured":"De Jonghe C, Kumar-Singh S, Cruts M, Kleinert R, Vanderstichele H, Vanmechelen EJM, et al. Unusual A\u03b2 amyloid deposition in Alzheimer\u2019s disease due tu an APP T714I mutation at the \u03b342-secretase site. Neurobiol Aging. 2000;21(1):S200.","journal-title":"Neurobiol Aging"},{"issue":"16","key":"3_CR81","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/hmg\/10.16.1665","volume":"10","author":"C Jonghe De","year":"2001","unstructured":"De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, et al. Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet. 2001;10(16):1665\u201371.","journal-title":"Hum Mol Genet"},{"issue":"1481","key":"3_CR82","first-page":"e7","volume":"3","author":"V Dobricic","year":"2012","unstructured":"Dobricic V, Stefanova E, Jankovic M, Gurunlian N, Novakovic I, Hardy J, et al. Genetic testing in familial and young-onset Alzheimer\u2019s disease: mutation spectrum in a Serbian cohort. Neurobiol Aging. 2012;3(1481):e7\u201312.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"3_CR83","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/hmg\/6.12.2087","volume":"6","author":"CB Eckman","year":"1997","unstructured":"Eckman CB, Mehta ND, Crook R, Perez-tur J, Prihar G, Pfeiffer E, et al. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43). Hum Mol Genet. 1997;6(12):2087\u20139.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3_CR84","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1212\/01.WNL.0000149761.70566.3E","volume":"64","author":"T. Edwards-Lee","year":"2005","unstructured":"Edwards-Lee T, Ringman JM, Chung J, Werner J, Morgan A, St George Hyslop P, et al. An African American family with early-onset Alzheimer disease and an APP (T714I) mutation. Neurology. 2005;64(2):377\u20139.","journal-title":"Neurology"},{"issue":"3","key":"3_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/hmg\/1.3.165","volume":"1","author":"L Fidani","year":"1992","unstructured":"Fidani L, Rooke K, Chartier-Harlin MC, Hughes D, Tanzi R, Mullan M, et al. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer\u2019s disease: identification of a further family with APP717 Val \u2192 Ile. Hum Mol Genet. 1992;1(3):165\u20138.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3_CR86","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1086\/302702","volume":"66","author":"U Finckh","year":"2000","unstructured":"Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, et al. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet. 2000;66(1):110\u20137.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3_CR87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10048-005-0211-x","volume":"6","author":"U Finckh","year":"2005","unstructured":"Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, et al. Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics. 2005;6(2):85\u20139.","journal-title":"Neurogenetics."},{"key":"3_CR88","doi-asserted-by":"crossref","unstructured":"Ghetti B, Hake AM, Murrell JR, Epperson F, Farlow MR, Vidal R, Spina S. Familial Alzheimer disease associated with the V717L amyloid precursor protein gene mutation: Neuropathological characterization. Alzheimers Dement. 2008;4 Suppl 4:T585.","DOI":"10.1016\/j.jalz.2008.05.1788"},{"issue":"6311","key":"3_CR89","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"4","key":"3_CR90","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1212\/01.WNL.0000197791.53828.2C","volume":"66","author":"AK Godbolt","year":"2006","unstructured":"Godbolt AK, Beck JA, Collinge JC, Cipolotti L, Fox NC, Rossor MN. A second family with familial AD and the V717L APP mutation has a later age at onset. Neurology. 2006;66(4):611\u20132.","journal-title":"Neurology"},{"issue":"1","key":"3_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/NEN.0b013e3181c6b84d","volume":"69","author":"C Guardia-Laguarta","year":"2010","unstructured":"Guardia-Laguarta C, Pera M, Clarim\u00f3n J, Molinuevo JL, S\u00e1nchez-Valle R, Llad\u00f3 A, et al. Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol. 2010;69(1):53\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"3_CR92","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"8753","key":"3_CR93","first-page":"1342","volume":"337","author":"J Hardy","year":"1991","unstructured":"Hardy J, Mullan M, Chartier-Harlin M-C, Brown J, Goate A, Rossor M, Collinge J, et al. Molecular classification of Alzheimer\u2019s disease. Lancet. 1991;337(8753):1342\u20133.","journal-title":"Lancet"},{"issue":"1","key":"3_CR94","first-page":"S311","volume":"23","author":"JC Janssen","year":"2002","unstructured":"Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, et al. Early onset familial Alzheimer\u2019s disease: mutation frequency in 31 families. Neurobiol Aging. 2002;23(1):S311.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3_CR95","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","volume":"60","author":"JC Janssen","year":"2003","unstructured":"Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, et al. Early onset familial Alzheimer\u2019s disease: mutation frequency in 31 families. Neurology. 2003;60(2):235\u20139.","journal-title":"Neurology"},{"issue":"8","key":"3_CR96","doi-asserted-by":"publisher","first-page":"1957.e1","DOI":"10.1016\/j.neurobiolaging.2014.02.014","volume":"35","author":"B Jiao","year":"2014","unstructured":"Jiao B, Tang B, Liu X, Xu J, Wang Y, Zhou L, et al. Mutational analysis in early-onset familial Alzheimer\u2019s disease in Mainland China. Neurobiol Aging. 2014;35(8):1957.e1\u20136.","journal-title":"Neurobiol Aging"},{"issue":"18","key":"3_CR97","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1093\/hmg\/9.18.2589","volume":"9","author":"S Kumar-Singh","year":"2000","unstructured":"Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, et al. Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated abeta(42) in Alzheimer\u2019s disease. Hum Mol Genet. 2000;9(18):2589\u201398.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3_CR98","first-page":"S91","volume":"19","author":"JBJ Kwok","year":"1998","unstructured":"Kwok JBJ, Li Q-X, Hallupp M, Milward L, Whyte S, Schofield PR. Novel familial early-onset Alzheimer\u2019s disease mutation (Leu723Pro) in amyloid precursor protein (APP) gene increases production of 42(43) amino-acid isoform of amyloid beta peptide. Neurobiol Aging. 1998;19(4):S91.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3_CR99","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/1531-8249(200002)47:2<249::AID-ANA18>3.0.CO;2-8","volume":"47","author":"JB Kwok","year":"2000","unstructured":"Kwok JB, Li QX, Hallupp M, Whyte S, Ames D, Beyreuther K, Masters CL, Schofield PR. Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis. Ann Neurol. 2000;47(2):249\u201353.","journal-title":"Ann Neurol"},{"issue":"6","key":"3_CR100","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1212\/WNL.46.6.1721","volume":"46","author":"Y Matsumura","year":"1996","unstructured":"Matsumura Y, Kitamura E, Miyoshi K, Yamamoto Y, Furuyama J, Sugihara T. Japanese siblings with missense mutation (717Val \u2192 Ile) in amyloid precursor protein of early-onset Alzheimer\u2019s disease. Neurology. 1996;46(6):1721\u20133.","journal-title":"Neurology"},{"issue":"5028","key":"3_CR101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1925564","volume":"254","author":"J Murrell","year":"1991","unstructured":"Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s disease. Science. 1991;254(5028):97\u20139.","journal-title":"Science"},{"key":"3_CR102","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archneur.57.6.885","volume":"57","author":"JR Murrell","year":"2000","unstructured":"Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B. Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol. 2000;57:885\u20137.","journal-title":"Arch Neurol"},{"issue":"8747","key":"3_CR103","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/0140-6736(91)91612-X","volume":"337","author":"S Naruse","year":"1991","unstructured":"Naruse S, Igarashi S, Kobayashi H, Aoki K, Inuzuka T, Kaneko K, et al. Mis-sense mutation Val \u2192 Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer\u2019s disease. Lancet. 1991;337(8747):978\u20139.","journal-title":"Lancet"},{"issue":"2","key":"3_CR104","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3346\/jkms.2008.23.2.213","volume":"23","author":"HK Park","year":"2008","unstructured":"Park HK, Na DL, Lee JH, Kim JW, Ki CS. Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer\u2019s disease. J Korean Med Sci. 2008;23(2):213\u20137.","journal-title":"J Korean Med Sci"},{"issue":"10","key":"3_CR105","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jmg.2005.033456","volume":"42","author":"G Raux","year":"2005","unstructured":"Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer\u2019s disease: an update. J Med Genet. 2005;42(10):793\u20135.","journal-title":"J Med Genet"},{"issue":"10","key":"3_CR106","doi-asserted-by":"publisher","first-page":"2422.e13-2422.e","DOI":"10.1016\/j.neurobiolaging.2014.04.026","volume":"35","author":"Celeste Sassi","year":"2014","unstructured":"Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, et al. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(10):2422.e13\u20136.","journal-title":"Neurobiology of Aging"},{"issue":"12","key":"3_CR107","doi-asserted-by":"publisher","first-page":"2881.e1","DOI":"10.1016\/j.neurobiolaging.2014.06.002","volume":"35","author":"C Sassi","year":"2014","unstructured":"Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(12):2881.e1\u20136.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3_CR108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ng0593-10","volume":"4","author":"S Sorbi","year":"1993","unstructured":"Sorbi S, Nacmias B, Forleo P, Piacentini S, Amaducci L, Provinciali L. APP717 and Alzheimer\u2019s disease in Italy. Nat Genet. 1993;4(1):10.","journal-title":"Nat Genet"},{"issue":"1","key":"3_CR109","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ana.410380120","volume":"38","author":"S Sorbi","year":"1995","unstructured":"Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer\u2019s disease. Ann Neurol. 1995;38(1):124\u20137.","journal-title":"Ann Neurol"},{"issue":"11","key":"3_CR110","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archneur.60.11.1541","volume":"60","author":"A Tedde","year":"2003","unstructured":"Tedde A, Nacmias B, Ciantelli M, Forleo P, Cellini E, Bagnoli S, et al. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease. Arch Neurol. 2003;60(11):1541\u20134.","journal-title":"Arch Neurol"},{"key":"3_CR111","unstructured":"Terreni L, Fogliarino S, Franceschi, Forloni G. Novel pathogenic mutation in an Italian patient with familial Alzheimer\u2019s disease detected in APP gene. Neurobiol Aging. 2002;23(1):S319."},{"issue":"3","key":"3_CR112","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/0006-291X(91)91011-Z","volume":"178","author":"K Yoshioka","year":"1991","unstructured":"Yoshioka K, Miki T, Katsuya T, Ogihara T, Sakaki Y. The 717Val \u2192 Ile substitution in amyloid precursor protein is associated with familial Alzheimer\u2019s disease regardless of ethnic groups. Biochem Biophys Res Commun. 1991;178(3):1141\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"3_CR113","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0022-510X(93)90147-Q","volume":"117","author":"T Yoshizawa","year":"1993","unstructured":"Yoshizawa T, Komatsuzaki Y, Iwamoto H, Mizusawa H, Kanazawa I. Screening of the mis-sense mutation producing the 717Val \u2192 Ile substitution in the amyloid precursor protein in Japanese familial and sporadic Alzheimer\u2019s disease. J Neurol Sci. 1993;117(1\u20132):12\u20135.","journal-title":"J Neurol Sci"},{"issue":"2","key":"3_CR114","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0014-4886(03)00384-4","volume":"184","author":"C Zekanowski","year":"2003","unstructured":"Zekanowski C, Styczynska M, Peplonska B, Gabryelewicz T, Religa D, Ilkowski J, et al. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer\u2019s disease in Poland. Exp Neurol. 2003;184(2):991\u20136.","journal-title":"Exp Neurol"},{"issue":"9","key":"3_CR115","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/humu.20402","volume":"27","author":"J Theuns","year":"2006","unstructured":"Theuns J, Marjaux E, Vandenbulcke M, Van Laere K, Kumar-Singh S, Bormans G, et al. Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment. Hum Mutat. 2006;27(9):888\u201396.","journal-title":"Hum Mutat"},{"issue":"9","key":"3_CR116","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1468-1331.2007.01664.x","volume":"14","author":"A Alberici","year":"2007","unstructured":"Alberici A, Bonato C, Borroni B, Cotelli M, Mattioli F, Binetti G, et al. Dementia, delusions and seizures: storage disease or genetic AD. Eur J Neurol. 2007;14(9):1057\u20139.","journal-title":"Eur J Neurol"},{"issue":"3","key":"3_CR117","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0304-3940(97)00950-6","volume":"240","author":"J Aldudo","year":"1998","unstructured":"Aldudo J, Bullido MJ, Arbizu T, Oliva R, Valdivieso F. Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer\u2019s disease. Neurosci Lett. 1998;240(3):174\u20136.","journal-title":"Neurosci Lett"},{"issue":"5","key":"3_CR118","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K","volume":"14","author":"J Aldudo","year":"1999","unstructured":"Aldudo J, Bullido MJ, Valdivieso F. DGGE method for the mutational analysis of the coding and proximal promoter regions of the Alzheimer\u2019s disease presenilin-1 gene: two novel mutations. Hum Mutat. 1999;14(5):433\u20139.","journal-title":"Hum Mutat"},{"issue":"1","key":"3_CR119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2011.03.084","volume":"496","author":"A Antonell","year":"2011","unstructured":"Antonell A, Balasa M, Oliva R, Llad\u00f3 A, Bosch B, Fabregat N, et al. A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer\u2019s disease. Neurosci Lett. 2011;496(1):40\u20132.","journal-title":"Neurosci Lett"},{"issue":"4","key":"3_CR120","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1212\/WNL.48.4.1118","volume":"48","author":"M Aoki","year":"1997","unstructured":"Aoki M, Abe K, Oda N, Ikeda M, Tsuda T, Kanai M, et al. A presenilin-1 mutation in a Japanese family with Alzheimer\u2019s disease and distinctive abnormalities on cranial MRI. Neurology. 1997;48(4):1118\u201320.","journal-title":"Neurology"},{"issue":"1","key":"3_CR121","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10048-007-0104-2","volume":"9","author":"N Arai","year":"2008","unstructured":"Arai N, Kishino A, Takahashi Y, Morita D, Nakamura K, Yokoyama T, et al. Familial cases presenting very early onset autosomal dominant Alzheimer\u2019s disease with I143T in presenilin-1 gene: implication for genotype-phenotype correlation. Neurogenetics. 2008;9(1):65\u20137.","journal-title":"Neurogenetics."},{"issue":"2","key":"3_CR122","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8","volume":"103","author":"D Arango","year":"2001","unstructured":"Arango D, Cruts M, Torres O, Backhovens H, Serrano ML, Villareal E, et al. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia. Am J Med Genet. 2001;103(2):138\u201343.","journal-title":"Am J Med Genet"},{"issue":"18","key":"3_CR123","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1001\/jama.286.18.2257","volume":"286","author":"ES Athan","year":"2001","unstructured":"Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, et al. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA. 2001;286(18):2256\u201363.","journal-title":"JAMA"},{"issue":"5","key":"3_CR124","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/archneur.55.5.698","volume":"55","author":"K Axelman","year":"1998","unstructured":"Axelman K, Basun H, Lannfelt L. Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch Neurol. 1998;55(5):698\u2013702.","journal-title":"Arch Neurol"},{"issue":"2","key":"3_CR125","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/WAD.0b013e31815a9dec","volume":"22","author":"S Batelli","year":"2008","unstructured":"Batelli S, Albani D, Prato F, Polito L, Franceschi M, Gavazzi A, Forloni G. Early-onset Alzheimer disease in an Italian family with presenilin-1 double mutation E318G and G394V. Alzheimer Dis Assoc Disord. 2008;22(2):184\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8994","key":"3_CR126","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0140-6736(96)90261-5","volume":"347","author":"K Boteva","year":"1996","unstructured":"Boteva K, Vitek M, Mitsuda H, de Silva H, Xu PT, Small G, Gilbert JR. Mutation analysis of presenillin 1 gene in Alzheimer\u2019s disease. Lancet. 1996;347(8994):130\u20131.","journal-title":"Lancet"},{"issue":"3","key":"3_CR127","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1016\/j.jalz.2006.05.699","volume":"2","author":"N Brouwers","year":"2006","unstructured":"Brouwers N, Sleegers K, Theuns J, Engelborghs S, Bogaerts V, Serneels S, et al. Contribution of dementia genes to Alzheimer\u2019s disease in Belgium. Alzheimer Dement. 2006;2(3):S191.","journal-title":"Alzheimer Dement."},{"key":"3_CR128","unstructured":"Cervenakova L, Brown P, Sandoval F, Foncin J-F, Garruto R, Polinsky RJ, et al. Identification of presenilin-1 gene point mutations in early-onset Alzheimer\u2019s disease families. Am J Hum Genet. 1996;59(Suppl):A252."},{"issue":"556","key":"3_CR129","first-page":"e1","volume":"32","author":"A Church","year":"2011","unstructured":"Church A, Prescott J, Lillis S, Rees J, Chance P, Williamson K, Morris HR. A novel presenilin 1 mutation, I202F occurring at a previously predicted pathogenic site causing autosomal dominant Alzheimer\u2019s disease. Neurobiol Aging. 2011;32(556):e1\u20132.","journal-title":"Neurobiol Aging"},{"issue":"Supp 2","key":"3_CR130","doi-asserted-by":"publisher","first-page":"T583","DOI":"10.1016\/j.jalz.2008.05.1780","volume":"4","author":"J Clarim\u00f3n","year":"2008","unstructured":"Clarim\u00f3n J, Guerreiro R, Lle\u00f3 A, Guardia C, Blesa F, G\u00f3mez-Isla T, et al. Genetic screening in a large cohort of early-onset Alzheimer\u2019s disease patients from Spain: novel mutations in the amyloid precursor protein and presenilines. Alzheimers Dement. 2008;4(Supp 2):T583.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"3_CR131","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng1095-219","volume":"11","author":"RF Clark","year":"1995","unstructured":"Clark RF, Hutton M, Fuldner RA, Froelich S, Karran E, Talbot C, et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995;11(2):219\u201322.","journal-title":"Nat Genet"},{"issue":"3","key":"3_CR132","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2004.04.030","volume":"364","author":"P Coleman","year":"2004","unstructured":"Coleman P, Kurlan R, Crook R, Werner J, Hardy J. A new presenilin Alzheimer\u2019s disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5. Neurosci Lett. 2004;364(3):139\u201340.","journal-title":"Neurosci Lett"},{"issue":"1","key":"3_CR133","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ana.410420121","volume":"42","author":"R Crook","year":"1997","unstructured":"Crook R, Ellis R, Shanks M, Thal LJ, Perez-Tur J, Baker M, et al. Early-onset Alzheimer\u2019s disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2. Ann Neurol. 1997;42(1):124\u20138.","journal-title":"Ann Neurol"},{"issue":"12","key":"3_CR134","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/hmg\/4.12.2363","volume":"4","author":"Marc Cruts","year":"1995","unstructured":"Cruts M, Backhovens H, Wang SY, Gassen GV, Theuns J, De Jonghe CD, Wehnert A, De Voecht J, De Winter G, Cras P, Bruyland M, Datson N, Weissenbach J, den Dunnen JT, Martin J-J, Hendriks L, Van Broeckhoven C. Molecular genetic analysis of familial early-onset Alzheimer\u2019s disease linked to chromosome 14q24.3. Hum Mol Genet. 1995;4(12):2363\u201372.","journal-title":"Human Molecular Genetics"},{"key":"3_CR135","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","volume":"7","author":"M Cruts","year":"1998","unstructured":"Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998;7:43\u201351.","journal-title":"Hum Mol Genet"},{"key":"3_CR136","unstructured":"Doran M, Larner AJ. Familial Alzheimer\u2019s disease due to presenilin-1 Y115C mutation. J Neurol. 2006;253 Suppl 2:ii91,2006."},{"issue":"1S","key":"3_CR137","first-page":"S219","volume":"23","author":"K Dowjat","year":"2002","unstructured":"Dowjat K, Kuchna I, Wisniewski K, Wisniewski T, Wegiel J. Another highly pathogenic Alzheimer presenilin-1 mutation in codon 117: genotype-phenotype comparison of P117S and P117L mutations. Neurobiol Aging. 2002;23(1S):S219.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3_CR138","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JAD-2004-6105","volume":"6","author":"WK Dowjat","year":"2004","unstructured":"Dowjat WK, Kuchna I, Wisniewski T, Wegiel J. A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations. J Alzheimers Dis. 2004;6(1):31\u201343.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"3_CR139","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jmg.35.8.672","volume":"35","author":"C Dumanchin","year":"1998","unstructured":"Dumanchin C, Brice A, Campion D, Hannequin D, Martin C, Moreau V, et al. De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer\u2019s disease cases. French Alzheimer\u2019s Disease Study Group. J Med Genet. 1998;35(8):672\u20133.","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"3_CR140","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neulet.2006.01.006","volume":"398","author":"T Edwards-Lee","year":"2006","unstructured":"Edwards-Lee T, Wen J, Bell J, Hardy J, Chung J, Momeni P. A presenilin-1 mutation (T245P) in transmembrane domain 6 causes early onset Alzheimer\u2019s disease. Neurosci Lett. 2006;398(3):251\u20132.","journal-title":"Neurosci Lett"},{"issue":"4","key":"3_CR141","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/archneur.57.4.485","volume":"57","author":"M Ezquerra","year":"2000","unstructured":"Ezquerra M, Carnero C, Blesa R, Oliva R. A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease. Arch Neurol. 2000;57(4):485\u20138.","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"3_CR142","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2006.06.072","volume":"406","author":"B Fang","year":"2006","unstructured":"Fang B, Jia L, Jia J. Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells. Neurosci Lett. 2006;406(1\u20132):33\u20137.","journal-title":"Neurosci Lett"},{"issue":"5","key":"3_CR143","first-page":"336","volume":"87","author":"BY Fang","year":"2007","unstructured":"Fang BY, Jia JP. The effect of two newly Chinese presenilin-1 mutations on the sensitivity to trophic factor withdrawal in human neuroblastoma cells. Zhonghua Yi Xue Za Zhi. 2007;87(5):336\u201340.","journal-title":"Zhonghua Yi Xue Za Zhi."},{"issue":"10","key":"3_CR144","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1212\/WNL.54.10.2006","volume":"54","author":"U Finckh","year":"2000","unstructured":"Finckh U, Alberici A, Antoniazzi M, Benussi L, Fedi V, Giannini C, Gal A, Nitsch RM, Binetti G. Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology. 2000;54(10):2006\u20138.","journal-title":"Neurology"},{"issue":"1","key":"3_CR145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0304-3940(97)00603-4","volume":"234","author":"C Forsell","year":"1997","unstructured":"Forsell C, Froelich S, Axelman K, Vestling M, Cowburn RF, Lilius L, et al. A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer\u2019s disease. Neurosci Lett. 1997;234(1):3\u20136.","journal-title":"Neurosci Lett"},{"issue":"3","key":"3_CR146","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JAD-2011-110185","volume":"25","author":"M Gallo","year":"2011","unstructured":"Gallo M, Marcello N, Curcio SA, Colao R, Geracitano S, Bernardi L, et al. A novel pathogenic PSEN1 mutation in a family with Alzheimer\u2019s disease: phenotypical and neuropathological features. J Alzheimers Dis. 2011;25(3):425\u201331.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3_CR147","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1533317509346209","volume":"24","author":"G Gliebus","year":"2009","unstructured":"Gliebus G, Rosso A, Lippa CF. Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier. Am J Alzheimers Dis Other Demen. 2009;24(6):456\u201360.","journal-title":"Am J Alzheimers Dis Other Demen."},{"key":"3_CR148","unstructured":"Golan M, Lipczynska-Lojkowska W, Krzysko KA, Styczynska M, Luczywek E, Filipek S, et al. Two novel mutations in presenilin 1 (PSEN1) gene connected with atypical familial early-onset Alzheimer\u2019s disease (EOAD). Alzheimer\u2019s and Parkinson\u2019s diseases: insights, progress and perspectives. In: 7th international conference AD\/PD 2005 book of abstracts: 24, 2005."},{"issue":"7","key":"3_CR149","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/gps.657","volume":"17","author":"JS Goldman","year":"2002","unstructured":"Goldman JS, Reed B, Gearhart R, Kramer JH, Miller BL. Very early-onset familial Alzheimer\u2019s disease: a novel presenilin 1 mutation. Int J Geriatr Psychiatry. 2002;17(7):649\u201351.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"3_CR150","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3233\/JAD-2010-1292","volume":"19","author":"E G\u00f3mez-Tortosa","year":"2010","unstructured":"G\u00f3mez-Tortosa E, Barquero S, Bar\u00f3n M, Gil-Neciga E, Castellanos F, Zurdo M, et al. Clinical-genetic correlations in familial Alzheimer\u2019s disease caused by presenilin 1 mutations. J Alzheimers Dis. 2010;19(3):873\u201384.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"3_CR151","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","volume":"31","author":"RJ Guerreiro","year":"2010","unstructured":"Guerreiro RJ, Baquero M, Blesa R, Boada M, Br\u00e1s JM, Bullido MJ, et al. Genetic screening of Alzheimer\u2019s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging. 2010;31(5):725\u201331.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"3_CR152","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s004390050688","volume":"102","author":"L Gustafson","year":"1998","unstructured":"Gustafson L, Brun A, Englund E, Hagnell O, Nilsson K, Stensmyr M, et al. A 50-year perspective of a family with chromosome-14-linked Alzheimer\u2019s disease. Hum Genet. 1998;102(3):253\u20137.","journal-title":"Hum Genet"},{"issue":"9","key":"3_CR153","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00415-009-5154-y","volume":"256","author":"T Hamaguchi","year":"2009","unstructured":"Hamaguchi T, Morinaga A, Tsukie T, Kuwano R, Yamada M. A novel presenilin 1 mutation (L282F) in familial Alzheimer\u2019s disease. J Neurol. 2009;256(9):1575\u20137.","journal-title":"J Neurol"},{"issue":"1","key":"3_CR154","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jnnp.64.1.44","volume":"64","author":"RJ Harvey","year":"1998","unstructured":"Harvey RJ, Ellison D, Hardy J, Hutton M, Roques PK, Collinge J, Fox NC, Rossor MN. Chromosome 14 familial Alzheimer\u2019s disease: the clinical and neuropathological characteristics of a family with a leucine \u2192 serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry. 1998;64(1):44\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 1","key":"3_CR155","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/brain\/awh009","volume":"127","author":"J Heckmann","year":"2004","unstructured":"Heckmann J, de Viliers C, Rutherfoord S, Ramesar R, Morris C, Low R, Kalaria R. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous South African family with early-onset Alzheimer\u2019s disease. Brain. 2004;127(Pt 1):133\u201342.","journal-title":"Brain"},{"issue":"4","key":"3_CR156","first-page":"227","volume":"3","author":"S Higuchi","year":"2000","unstructured":"Higuchi S, Yoshino A, Matsui T, Matsushita S, Satoh A, Iimura T, et al. A novel PS1 Mutation (W165G) in a Japanese family with early-onset Alzheimer\u2019s disease. Alzheimers Rep. 2000;3(4):227\u201331.","journal-title":"Alzheimers Rep."},{"issue":"1\u20132","key":"3_CR157","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0304-3940(01)02254-6","volume":"313","author":"H Houlden","year":"2001","unstructured":"Houlden H, Crook R, Dolan RJ, McLaughlin J, Revesz T, Hardy J. A novel presenilin mutation (M233V) causing very early onset Alzheimer\u2019s disease with Lewy bodies. Neurosci Lett. 2001;313(1\u20132):93\u20135.","journal-title":"Neurosci Lett"},{"issue":"3","key":"3_CR158","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/00001756-199602290-00029","volume":"7","author":"M Hutton","year":"1996","unstructured":"Hutton M, Busfield F, Wragg M, Crook R, Perez-Tur J, Clark RF, et al. Complete analysis of the presenilin 1 gene in early onset Alzheimer\u2019s disease. NeuroReport. 1996;7(3):801\u20135.","journal-title":"NeuroReport"},{"issue":"6","key":"3_CR159","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ana.410400614","volume":"40","author":"M Ikeda","year":"1996","unstructured":"Ikeda M, Sharma V, Sumi SM, Rogaeva EA, Poorkaj P, Sherrington R, et al. The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients. Ann Neurol. 1996;40(6):912\u20137.","journal-title":"Ann Neurol"},{"issue":"2","key":"3_CR160","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/13506129.2013.790810","volume":"20","author":"M Ikeda","year":"2013","unstructured":"Ikeda M, Yonemura K, Kakuda S, Tashiro Y, Fujita Y, Takai E, et al. Cerebrospinal fluid levels of phosphorylated tau and A\u00df1-38\/A\u00df1-40\/A\u00df1-42 in Alzheimer\u2019s disease with PS1 mutations. Amyloid. 2013;20(2):107\u201312.","journal-title":"Amyloid"},{"issue":"1","key":"3_CR161","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000141483","volume":"26","author":"Takeshi Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kaneko H, Miyashita A, Nozaki H, Kasuga K, Tsukie T, et al. Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406\u00a0W mutations. Dement Geriatr Cogn Disord. 2008;26(1):43\u20139.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"1","key":"3_CR162","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/S0197-4580(00)82130-2","volume":"21","author":"M Jacquier","year":"2000","unstructured":"Jacquier M, Arango D, Torres O, Cruts M, Serrano M, Matallana M, et al. Presenilin mutations in a Colombian familial and sporadic AD sample. Neurobiol Aging. 2000;21(1):S176.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"3_CR163","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/archneur.58.6.953","volume":"58","author":"JC Janssen","year":"2001","unstructured":"Janssen JC, Lantos PL, Fox NC, Harvey RJ, Beck J, Dickinson A, et al. Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation. Arch Neurol. 2001;58(6):953\u20138.","journal-title":"Arch Neurol"},{"issue":"2","key":"3_CR164","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2005-7204","volume":"7","author":"J Jia","year":"2005","unstructured":"Jia J, Xu E, Shao Y, Jia J, Sun Y, Li D. One novel presenilin-1 gene mutation in a Chinese pedigree of familial Alzheimer\u2019s disease. J Alzheimers Dis. 2005;7(2):119\u201324.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3_CR165","doi-asserted-by":"publisher","first-page":"1602.e3-1602.e6","DOI":"10.1016\/j.neurobiolaging.2014.11.009","volume":"36","author":"Hong-Yan Jiang","year":"2015","unstructured":"Jiang HY, Li GD, Dai SX, Bi R, Zhang DF, Li ZF, et al. Identification of PSEN1 mutations p.M233L and p.R352C in Han Chinese families with early-onset familial Alzheimer\u2019s disease. Neurobiol Aging. 2015;36(3):1602.e3\u20136.","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"3_CR166","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/alzrt137","volume":"4","author":"SC Jin","year":"2012","unstructured":"Jin SC, Pastor P, Cooper B, Cervantes S, Benitez BA, Razquin C, Goate A, et al. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer\u2019s disease Ibero-American cohort. Alzheimers Res Ther. 2012;4(4):34.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"3_CR167","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1399-0004.1996.tb02375.x","volume":"50","author":"P Jorgensen","year":"1996","unstructured":"Jorgensen P, Bus C, Pallisgaard N, Bryder M, Jorgensen AL. Familial Alzheimer\u2019s disease co-segregates with a Met146I1e substitution in presenilin-1. Clin Genet. 1996;50(5):281\u20136.","journal-title":"Clin Genet"},{"issue":"1","key":"3_CR168","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0022-510X(98)00219-6","volume":"160","author":"K Kamimura","year":"1998","unstructured":"Kamimura K, Tanahashi H, Yamanaka H, Takahashi K, Asada T, Tabira T. Familial Alzheimer\u2019s disease genes in Japanese. J Neurol Sci. 1998;160(1):76\u201381.","journal-title":"J Neurol Sci"},{"issue":"3","key":"3_CR169","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3940(96)12587-8","volume":"208","author":"K Kamino","year":"1996","unstructured":"Kamino K, Sato S, Sakaki Y, Yoshiiwa A, Nishiwaki Y, Takeda M, et al. Three different mutations of presenilin 1 gene in early-onset Alzheimer\u2019s disease families. Neurosci Lett. 1996;208(3):195\u20138.","journal-title":"Neurosci Lett"},{"issue":"8","key":"3_CR170","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00415-009-5096-4","volume":"256","author":"K Kasuga","year":"2009","unstructured":"Kasuga K, Ohno T, Ishihara T, Miyashita A, Kuwano R, Onodera O, et al. Depression and psychiatric symptoms preceding onset of dementia in a family with early-onset Alzheimer disease with a novel PSEN1 mutation. J Neurol. 2009;256(8):1351\u20133.","journal-title":"J Neurol"},{"issue":"5","key":"3_CR171","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ana.21099","volume":"61","author":"JS Kauwe","year":"2007","unstructured":"Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, et al. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer\u2019s disease presenilin 1 mutation. Ann Neurol. 2007;61(5):446\u201353.","journal-title":"Ann Neurol"},{"issue":"2","key":"3_CR172","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neulet.2012.10.037","volume":"531","author":"GA Kerchner","year":"2012","unstructured":"Kerchner GA, Holbrook K. Novel presenilin-1 Y159F sequence variant associated with early-onset Alzheimer\u2019s disease. Neurosci Lett. 2012;531(2):142\u20134.","journal-title":"Neurosci Lett"},{"issue":"6","key":"3_CR173","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10072-010-0233-5","volume":"31","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Kim HY, Ki CS, Kim SH. Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer\u2019s disease: clinical characteristics and genetic identification. Neurol Sci. 2010;31(6):781\u20133.","journal-title":"Neurol Sci."},{"issue":"2","key":"3_CR174","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2012.09.040","volume":"530","author":"J Kim","year":"2012","unstructured":"Kim J, Bagyinszky E, Chang YH, Choe G, Choi BO, An SS, Kim S. A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer\u2019s disease: clinical, neuroimaging, and neuropathological findings. Neurosci Lett. 2012;530(2):109\u201314.","journal-title":"Neurosci Lett"},{"issue":"4","key":"3_CR175","first-page":"256","volume":"18","author":"HH Klunemann","year":"2004","unstructured":"Klunemann HH, Rogaeva E, Neumann M, Kretzschmar HA, Kandel M, Toulina A, et al. Novel PS1 mutation in a Bavarian kindred with familial Alzheimer disease. Alzheimer Dis Assoc Disord. 2004;18(4):256\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"3_CR176","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1468-1331.2007.01857.x","volume":"14","author":"W. D. Knight","year":"2007","unstructured":"Knight WD, Kennedy J, Mead S, Rossor MN, Beck J, Collinge J, Mummery C. A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer\u2019s disease. Eur J Neurol. 2007;14(7):829\u201331.","journal-title":"European Journal of Neurology"},{"issue":"2","key":"3_CR177","first-page":"231","volume":"44","author":"A Kowalska","year":"2003","unstructured":"Kowalska A, Wender M, Florczak J, Pruchnik-Wolinska D, Modestowicz R, Szczech J, et al. Molecular genetics of Alzheimer\u2019s disease: presenilin 1 gene analysis in a cohort of patients from the Poznan region. J Appl Genet. 2003;44(2):231\u20134.","journal-title":"J Appl Genet."},{"issue":"1","key":"3_CR178","doi-asserted-by":"crossref","first-page":"245","DOI":"10.18388\/abp.2004_3617","volume":"51","author":"A Kowalska","year":"2004","unstructured":"Kowalska A, Pruchnik-Wolinska D, Florczak J, Modestowicz R, Szczech J, Kozubski W, et al. Genetic study of familial cases of Alzheimer\u2019s disease. Acta Biochim Pol. 2004;51(1):245\u201352.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"3_CR179","first-page":"9","volume":"42","author":"A Kowalska","year":"2004","unstructured":"Kowalska A, Pruchnik-Wolinska D, Florczak J, Szczech J, Kozubski W, Rossa G, Wender M. Presenilin 1 mutations in Polish families with early-onset Alzheimer\u2019s disease. Folia Neuropathol. 2004;42(1):9\u201314.","journal-title":"Folia Neuropathol"},{"issue":"6","key":"3_CR180","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1097\/00001756-199704140-00043","volume":"8","author":"JB Kwok","year":"1997","unstructured":"Kwok JB, Taddei K, Hallupp M, Fisher C, Brooks WS, Broe GA, et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer\u2019s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. NeuroReport. 1997;8(6):1537\u201342.","journal-title":"NeuroReport"},{"issue":"9","key":"3_CR181","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1074\/jbc.M211827200","volume":"278","author":"JB Kwok","year":"2003","unstructured":"Kwok JB, Halliday GM, Brooks WS, Dolios G, Laudon H, Murayama O, et al. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer\u2019s disease with non-cored plaques and no neuritic dystrophy. J Biol Chem. 2003;278(9):6748\u201354.","journal-title":"J Biol Chem"},{"issue":"8","key":"3_CR182","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1468-1331.2004.00828.x","volume":"11","author":"V Bella La","year":"2004","unstructured":"La Bella V, Liguori M, Cittadella R, Settipani N, Piccoli T, Manna I, Quattrone A, Piccoli F. A novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early-onset Alzheimer\u2019s disease. Eur J Neurol. 2004;11(8):521\u20134.","journal-title":"Eur J Neurol"},{"issue":"12","key":"3_CR183","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1212\/01.wnl.0000219762.28324.a6","volume":"66","author":"P Lee","year":"2006","unstructured":"Lee P, Medina L, Ringman JM. The Thr354Ile substitution in PSEN1: disease-causing mutation or polymorphism? Neurology. 2006;66(12):1955\u20136.","journal-title":"Neurology"},{"issue":"5","key":"3_CR184","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mgg3.85","volume":"2","author":"JH Lee","year":"2014","unstructured":"Lee JH, Kahn A, Cheng R, Reitz C, Vardarajan B, Lantigua R, Medrano M, et al. Disease-related mutations among Caribbean Hispanics with familial dementia. Mol Genet Genomic Med. 2014;2(5):430\u20137.","journal-title":"Mol Genet Genomic Med."},{"issue":"3","key":"3_CR185","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.0.CO;2-H","volume":"10","author":"CL Lendon","year":"1997","unstructured":"Lendon CL, Martinez A, Behrens IM, Kosik KS, Madrigal L, Norton J, et al. E280A PS-1 mutation causes Alzheimer\u2019s disease but age of onset is not modified by ApoE alleles. Hum Mutat. 1997;10(3):186\u201395.","journal-title":"Hum Mutat"},{"issue":"2","key":"3_CR186","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1399-0004.2009.01191.x","volume":"76","author":"S Lindquist","year":"2009","unstructured":"Lindquist S, Schwartz M, Batbayli M, Waldemar G, Nielsen J. Genetic testing in familial AD and FTD: Mutation and phenotype spectrum in a Danish cohort. Clin Genet. 2009;76(2):205\u20139.","journal-title":"Clin Genet"},{"issue":"1","key":"3_CR187","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0213-4853(10)70017-7","volume":"25","author":"A Llad\u00f3","year":"2010","unstructured":"Llad\u00f3 A, S\u00e1nchez-Valle R, Rey MJ, Mercadal P, Almenar C, L\u00f3pez-Villegas D, Fortea J, Molinuevo JL. New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer\u2019s disease. Neurologia. 2010;25(1):13\u20136.","journal-title":"Neurologia."},{"issue":"11","key":"3_CR188","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1001\/archneur.59.11.1759","volume":"59","author":"A Lleo","year":"2002","unstructured":"Lleo A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Pena-Casanova J, Rojo A, Oliva R. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Arch Neurol. 2002;59(11):1759\u201363.","journal-title":"Arch Neurol"},{"issue":"8","key":"3_CR189","doi-asserted-by":"publisher","first-page":"1850.e17","DOI":"10.1016\/j.neurobiolaging.2012.02.020","volume":"33","author":"E Lohmann","year":"2012","unstructured":"Lohmann E, Guerreiro RJ, Erginel-Unaltuna N, Gurunlian N, Bilgic B, Gurvit H, et al. Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiol Aging. 2012;33(8):1850.e17\u201327.","journal-title":"Neurobiol Aging"},{"key":"3_CR190","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2014.02.034","volume":"566","author":"D Luedecke","year":"2014","unstructured":"Luedecke D, Becktepe JS, Lehmbeck JT, Finckh U, Yamamoto R, Jahn H, Boelmans K. A novel presenilin 1 mutation (Ala275Val) as cause of early-onset familial Alzheimer disease. Neurosci Lett. 2014;566:115\u20139.","journal-title":"Neurosci Lett"},{"issue":"5","key":"3_CR191","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0197-4580(02)00192-6","volume":"24","author":"J Miklossy","year":"2003","unstructured":"Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, et al. Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2003;24(5):655\u201362.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3_CR192","first-page":"S322","volume":"23","author":"L Miravalle","year":"2002","unstructured":"Miravalle L, Murrell JR, Takao M, Glazier B, Piccardo P, Vidal R, Ghetti B. Genetic mutations associated with presenile dementia. Neurobiol Aging. 2002;23(1):S322.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"3_CR193","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1073\/pnas.112686799","volume":"99","author":"T Moehlmann","year":"2002","unstructured":"Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci USA. 2002;99(12):8025\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3_CR194","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1399-0004.1998.tb02597.x","volume":"53","author":"L Morelli","year":"1998","unstructured":"Morelli L, Prat MI, Levy E, Mangone CA, Castano EM. Presenilin 1 Met146Leu variant due to an A \u2192 T transversion in an early-onset familial Alzheimer\u2019s disease pedigree from Argentina. Clin Genet. 1998;53(6):469\u201373.","journal-title":"Clin Genet"},{"issue":"6","key":"3_CR195","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1212\/WNL.0b013e3181b163ba","volume":"73","author":"JB Norton","year":"2009","unstructured":"Norton JB, Cairns NJ, Chakraverty S, Wang J, Levitch D, Galvin JE, Goate A. Presenilin1 G217R mutation linked to Alzheimer disease with cotton wool plaques. Neurology. 2009;73(6):480\u20132.","journal-title":"Neurology"},{"issue":"3","key":"3_CR196","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)13:3<256::AID-HUMU11>3.0.CO;2-P","volume":"13","author":"MS Palmer","year":"1999","unstructured":"Palmer MS, Beck JA, Campbell TA, Humphries CB, Roques PK, Fox NC, Harvey R, Rossor MN, Collinge J. Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset Alzheimer\u2019s disease in the UK. Hum Mutat. 1999;13(3):256.","journal-title":"Hum Mutat"},{"issue":"5","key":"3_CR197","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10072-005-0499-1","volume":"26","author":"R Pantieri","year":"2005","unstructured":"Pantieri R, Pardini M, Cecconi M, Dagna-Bricarelli F, Vitali A, Piccini A, et al. A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer\u2019s disease. Neurol Sci. 2005;26(5):349\u201350.","journal-title":"Neurol Sci."},{"issue":"3","key":"3_CR198","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.0.CO;2-F","volume":"11","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj P, Sharma V, Anderson L, Nemens E, Alonso ME, Orr H, et al. Missense mutations in the chromosome 14 familial Alzheimer\u2019s disease presenilin 1 gene. Hum Mutat. 1998;11(3):216\u201321.","journal-title":"Hum Mutat"},{"issue":"8","key":"3_CR199","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1212\/01.WNL.0000086811.39675.79","volume":"61","author":"F Portet","year":"2003","unstructured":"Portet F, Dauvilliers Y, Campion D, Raux G, Hauw JJ, Lyon-Caen O, et al. Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu). Neurology. 2003;61(8):1136\u20137.","journal-title":"Neurology"},{"issue":"3","key":"3_CR200","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0304-3940(01)01498-7","volume":"299","author":"R Queralt","year":"2001","unstructured":"Queralt R, Ezquerra M, Castellvi M, Lleo A, Blesa R, Oliva R. Detection of the presenilin 1 gene mutation (M139T) in early-onset familial Alzheimer disease in Spain. Neurosci Lett. 2001;299(3):239\u201341.","journal-title":"Neurosci Lett"},{"issue":"3","key":"3_CR201","first-page":"149","volume":"41","author":"MG Ramirez-Duenas","year":"1998","unstructured":"Ramirez-Duenas MG, Rogaeva EA, Leal CA, Lin C, Ramirez-Casillas GA, Hernandez-Romo JA, et al. A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early onset Alzheimer disease. Ann Genet. 1998;41(3):149\u201353.","journal-title":"Ann Genet"},{"issue":"6","key":"3_CR202","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s004390050288","volume":"98","author":"Haike Reznik-Wolf","year":"1996","unstructured":"Reznik-Wolf H, Treves TA, Davidson M, Aharon-Peretz J, St George Hyslop PH, Chapman J, et al. A novel mutation of presenilin 1 in familial Alzheimer\u2019s disease in Israel detected by denaturing gradient gel electrophoresis. Hum Genet. 1996;98(6):700\u20132.","journal-title":"Human Genetics"},{"issue":"3","key":"3_CR203","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neulet.2010.10.039","volume":"487","author":"JM Ringman","year":"2011","unstructured":"Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, et al. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer\u2019s disease due to a novel PSEN1 mutation. Neurosci Lett. 2011;487(3):287\u201392.","journal-title":"Neurosci Lett"},{"issue":"6543","key":"3_CR204","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376(6543):775\u20138.","journal-title":"Nature"},{"issue":"4","key":"3_CR205","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1212\/WNL.57.4.621","volume":"57","author":"EA Rogaeva","year":"2001","unstructured":"Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, et al. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology. 2001;57(4):621\u20135.","journal-title":"Neurology"},{"issue":"11","key":"3_CR206","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/00001756-199908020-00006","volume":"10","author":"I Romero","year":"1999","unstructured":"Romero I, Jorgensen P, Bolwig G, Fraser PE, Rogaeva E, Mann D, et al. A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer\u2019s disease. NeuroReport. 1999;10(11):2255\u201360.","journal-title":"NeuroReport"},{"issue":"9014","key":"3_CR207","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(96)90715-1","volume":"347","author":"MN Rossor","year":"1996","unstructured":"Rossor MN, Fox NC, Beck J, Campbell TC, Collinge J. Incomplete penetrance of familial Alzheimer\u2019s disease in a pedigree with a novel presenilin-1 gene mutation. Lancet. 1996;347(9014):1560.","journal-title":"Lancet"},{"issue":"6534","key":"3_CR208","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature"},{"issue":"3","key":"3_CR209","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1440-1789.2007.00766.x","volume":"27","author":"AE Shrimpton","year":"2007","unstructured":"Shrimpton AE, Schelper RL, Linke RP, Hardy J, Crook R, Dickson DW, et al. A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis. Neuropathology. 2007;27(3):228\u201332.","journal-title":"Neuropathology."},{"issue":"3","key":"3_CR210","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00001756-199902250-00011","volume":"10","author":"MJ Smith","year":"1999","unstructured":"Smith MJ, Gardner RJ, Knight MA, Forrest SM, Beyreuther K, Storey E, et al. Early-onset Alzheimer\u2019s disease caused by a novel mutation at codon 219 of the presenilin-1 gene. NeuroReport. 1999;10(3):503\u20137.","journal-title":"NeuroReport"},{"issue":"1","key":"3_CR211","first-page":"S312","volume":"23","author":"S Sorbi","year":"2002","unstructured":"Sorbi S, Tedde A, Nacmias B, Ciantelli M, Caffarra P, Ghidoni E, et al. Novel presenilin 1 and presenilin 2 mutations in early-onset Alzheimer\u2019s disease families. Neurobiol Aging. 2002;23(1):S312.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3_CR212","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<90::AID-HUMU19>3.0.CO;2-S","volume":"14","author":"N Sugiyama","year":"1999","unstructured":"Sugiyama N, Suzuki K, Matsumura T, Kawanishi C, Onishi H, Yamada Y, et al. A novel missense mutation (G209R) in exon 8 of the presenilin 1 gene in a Japanese family with presenile familial Alzheimer\u2019s disease. Hum Mutat. 1999;14(1):90.","journal-title":"Hum Mutat"},{"issue":"2","key":"3_CR213","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3940(96)13138-4","volume":"218","author":"H Tanahashi","year":"1996","unstructured":"Tanahashi H, Kawakatsu S, Kaneko M, Yamanaka H, Takahashi K, Tabira T. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer\u2019s disease patients. Neurosci Lett. 1996;218(2):139\u201341.","journal-title":"Neurosci Lett"},{"key":"3_CR214","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neulet.2015.11.004","volume":"610","author":"A Tedde","year":"2016","unstructured":"Tedde A, Bartoli A, Piaceri I, Ferrara S, Bagnoli S, Serio A, et al. Novel presenilin 1 mutation (Ile408Thr) in an Italian family with late-onset Alzheimer\u2019s disease. Neurosci Lett. 2016;610:150\u20133.","journal-title":"Neurosci Lett"},{"issue":"1","key":"3_CR215","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0197-4580(00)82132-6","volume":"21","author":"L Terreni","year":"2000","unstructured":"Terreni L, Valeria C, Calella AM, Gavazzi A, Alberoni M, Grimaldi LM, et al. A novel missense mutation (L219F) in exon 8 of the presenilin 1 gene in an Italian family with presenile familial Alzheimer\u2019s disease. Neurobiol Aging. 2000;21(1):176\u20137.","journal-title":"Neurobiol Aging"},{"key":"3_CR216","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2013.03.056","volume":"544","author":"H.O. Tiedt","year":"2013","unstructured":"Tiedt HO, Lueschow A, Winter P, M\u00fcller U. Previously not recognized deletion in presenilin-1 (p.Leu174del.) in a patient with early-onset familial Alzheimer\u2019s disease. Neurosci Lett. 2013;544:115\u20138.","journal-title":"Neuroscience Letters"},{"issue":"2","key":"3_CR217","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-131844","volume":"40","author":"SK Ting","year":"2014","unstructured":"Ting SK, Benzinger T, Kepe V, Fagan A, Coppola G, Porter V, et al. A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer\u2019s disease in an African-American woman. J Alzheimers Dis. 2014;40(2):271\u20135.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"3_CR218","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nm0995-848a","volume":"1","author":"W Wasco","year":"1995","unstructured":"Wasco W, Pettingell WP, Jondro PD, Schmidt SD, Gurubhagavatula S, Rodes L, et al. Familial Alzheimer\u2019s chromosome 14 mutations. Nat Med. 1995;1(9):848.","journal-title":"Nat Med"},{"issue":"2","key":"3_CR219","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00001756-199801260-00008","volume":"9","author":"T Wisniewski","year":"1998","unstructured":"Wisniewski T, Dowjat WK, Buxbaum JD, Khorkova O, Efthimiopoulos S, Kulczycki J, et al. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer\u2019s disease and leads to death as early as the age of 28 years. NeuroReport. 1998;9(2):217\u201321.","journal-title":"NeuroReport"},{"issue":"7","key":"3_CR220","doi-asserted-by":"publisher","first-page":"1780.e1","DOI":"10.1016\/j.neurobiolaging.2014.01.023","volume":"35","author":"R Yagi","year":"2014","unstructured":"Yagi R, Miyamoto R, Morino H, Izumi Y, Kuramochi M, Kurashige T, et al. Detecting gene mutations in Japanese Alzheimer\u2019s patients by semiconductor sequencing. Neurobiol Aging. 2014;35(7):1780.e1\u20135.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3_CR221","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3940(97)00569-7","volume":"232","author":"M Yasuda","year":"1997","unstructured":"Yasuda M, Maeda K, Ikejiri Y, Kawamata T, Kuroda S, Tanaka C. A novel missense mutation in the presenilin-1 gene in a familial Alzheimer\u2019s disease pedigree with abundant amyloid angiopathy. Neurosci Lett. 1997;232(1):29\u201332.","journal-title":"Neurosci Lett"},{"issue":"1","key":"3_CR222","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneur.56.1.65","volume":"56","author":"M Yasuda","year":"1999","unstructured":"Yasuda M, Maeda K, Hashimoto M, Yamashita H, Ikejiri Y, Bird TD, et al. A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2. Arch Neurol. 1999;56(1):65\u20139.","journal-title":"Arch Neurol"},{"issue":"2","key":"3_CR223","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/jnnp.68.2.220","volume":"68","author":"M Yasuda","year":"2000","unstructured":"Yasuda M, Maeda S, Kawamata T, Tamaoka A, Yamamoto Y, Kuroda S, et al. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry. 2000;68(2):220\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3_CR224","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2006.01.022","volume":"200","author":"C Zekanowski","year":"2006","unstructured":"Zekanowski C, Golan MP, Krzysko KA, Lipczynska-Lojkowska W, Filipek S, Kowalska A, et al. Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment. Exp Neurol. 2006;200(1):82\u20138.","journal-title":"Exp Neurol"},{"issue":"3","key":"3_CR225","first-page":"1539","volume":"8","author":"C Jonghe De","year":"1999","unstructured":"De Jonghe C, Cruts M, Rogaeva EA, Tysoe C, Singleton A, Vanderstichele H, et al. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer\u2019s disease by increased Abeta42 secretion. Hum Mol Genet. 1999;8(3):1539\u201340.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3_CR226","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2009.10.055","volume":"468","author":"J Guo","year":"2010","unstructured":"Guo J, Wei J, Liao S, Wang L, Jiang H, Tang B. A novel presenilin 1 mutation (Ser169del) in a Chinese family with early-onset Alzheimer\u2019s disease. Neurosci Lett. 2010;468(1):34\u20137.","journal-title":"Neurosci Lett"},{"issue":"1","key":"3_CR227","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1086\/301672","volume":"62","author":"C Tysoe","year":"1998","unstructured":"Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, et al. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet. 1998;62(1):70\u20136.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"3_CR228","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00415-008-0764-3","volume":"255","author":"L Bernardi","year":"2008","unstructured":"Bernardi L, Tomaino C, Anfossi M, Gallo M, Geracitano S, Puccio G, et al. Late onset familial Alzheimer\u2019s disease: novel presenilin 2 mutation and PS1 E318G polymorphism. J Neurol. 2008;255(4):604\u20136.","journal-title":"J Neurol"},{"issue":"4","key":"3_CR229","first-page":"S87","volume":"19","author":"K Beyer","year":"1998","unstructured":"Beyer K, Lao JI, Fernand\u00e1ndez-Novoa L, Cacabelos R. Identification of a novel mutation (V148I) in the TM2 domain of the presenilin 2 gene in a patient with late-onset Alzheimer disease. Neurob Aging. 1998;19(4):S87.","journal-title":"Neurob Aging."},{"issue":"8","key":"3_CR230","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1212\/01.wnl.0000278386.00035.21","volume":"70","author":"N Ertekin-Taner","year":"2008","unstructured":"Ertekin-Taner N, Younkin LH, Yager DM, Parfitt F, Baker MC, Asthana S, et al. Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology. 2008;70(8):596\u2013606.","journal-title":"Neurology"},{"issue":"8","key":"3_CR231","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/archneur.60.8.1149","volume":"60","author":"M Ezquerra","year":"2003","unstructured":"Ezquerra M, Lleo A, Castellvi M, Queralt R, Santacruz P, Pastor P, et al. A novel mutation in the PSEN2 gene (T430\u00a0M) associated with variable expression in a family with early-onset Alzheimer disease. Arch Neurol. 2003;60(8):1149\u201351.","journal-title":"Arch Neurol"},{"key":"3_CR232","doi-asserted-by":"crossref","unstructured":"Gallo M, Tomaino C, Bernardi L, Maletta R, Anfossi M, Geracitano S, et al. PS1 polymporphism and a novel PS2 mutation in a patient with late-onset familial Alzheimer\u2019s disease. Alzheimers Dement. 2008;4(4):Suppl:T585.","DOI":"10.1016\/j.jalz.2008.05.1787"},{"issue":"3","key":"3_CR233","doi-asserted-by":"publisher","first-page":"e9510","DOI":"10.1371\/journal.pone.0009510","volume":"5","author":"Rita J. Guerreiro","year":"2010","unstructured":"Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, Schott JM, et al. Genetic variability in CLU and its association with Alzheimer\u2019s disease. PLoS ONE. 2010;5(3):e9510.","journal-title":"PLoS ONE"},{"issue":"4","key":"3_CR234","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s100480050044","volume":"1","author":"JI Lao","year":"1998","unstructured":"Lao JI, Beyer K, Fernandez-Novoa L, Cacabelos R. A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset Alzheimer\u2019s disease. Neurogenetics. 1998;1(4):293\u20136.","journal-title":"Neurogenetics."},{"issue":"6","key":"3_CR235","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1086\/509900","volume":"79","author":"D Li","year":"2006","unstructured":"Li D, Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S, et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet. 2006;79(6):1030\u20139.","journal-title":"Am J Hum Genet"},{"issue":"10","key":"3_CR236","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1468-1331.2008.02256.x","volume":"15","author":"SG Lindquist","year":"2008","unstructured":"Lindquist SG, Hasholt L, Bahl JM, Heegaard NH, Andersen BB, N\u00f8rrem\u00f8lle A, et al. A novel presenilin 2 mutation (V393\u00a0M) in early-onset dementia with profound language impairment. Eur J Neurol. 2008;15(10):1135\u20139.","journal-title":"Eur J Neurol"},{"issue":"10","key":"3_CR237","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1212\/WNL.57.10.1926","volume":"57","author":"A Lleo","year":"2001","unstructured":"Lleo A, Blesa R, Gendre J, Castellvi M, Pastor P, Queralt R, Oliva R. A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer\u2019s disease. Neurology. 2001;57(10):1926\u20138.","journal-title":"Neurology"},{"issue":"1","key":"3_CR238","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JAD-140399","volume":"42","author":"U M\u00fcller","year":"2014","unstructured":"M\u00fcller U, Winter P, Bolender C, Nolte D. Previously unrecognized missense mutation E126\u00a0K of PSEN2 segregates with early onset Alzheimer\u2019s disease in a family. J Alzheimers Dis. 2014;42(1):109\u201313.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"3_CR239","doi-asserted-by":"publisher","first-page":"2420.e1","DOI":"10.1016\/j.neurobiolaging.2014.04.011","volume":"35","author":"F Niu","year":"2014","unstructured":"Niu F, Yu S, Zhang Z, Yi X, Ye L, Tang W, Qiu C, Wen H, Sun Y, Gao J, Guo Y. Novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer\u2019s disease in a Chinese Han family. Neurobiol Aging. 2014;35(10):2420.e1\u20135.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3_CR240","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/JAD-2010-1369","volume":"20","author":"P Piscopo","year":"2010","unstructured":"Piscopo P, Talarico G, Crestini A, Gasparini M, Malvezzi-Campeggi L, Piacentini E, et al. A novel mutation in the predicted TMIII domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer\u2019s disease. J Alzheimers Dis. 2010;20(1):43\u20137.","journal-title":"J Alzheimers Dis"},{"key":"3_CR241","doi-asserted-by":"crossref","unstructured":"Piscopo P, Talarico G, Spadoni O, Malvezzi-Campeggi L, Crestini A, Gasparini M, et al. A novel Italian presenilin 2 mutation (S175Y). Alzheimers Dement. 2008;4(4):Suppl 2:T595.","DOI":"10.1016\/j.jalz.2008.05.1819"},{"issue":"Pt7","key":"3_CR242","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/brain\/awh179","volume":"127","author":"K Sleegers","year":"2004","unstructured":"Sleegers K, Roks G, Theuns J, Aulchenko YS, Rademakers R, Cruts M, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain. 2004;127(Pt7):1641\u20139.","journal-title":"Brain"},{"issue":"3","key":"3_CR243","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00415-006-0373-y","volume":"254","author":"C Tomaino","year":"2007","unstructured":"Tomaino C, Bernardi L, Anfossi M, Costanzo A, Ferrise F, Gallo M, et al. Presenilin 2 Ser130Leu mutation in a case of late-onset \u201csporadic\u201d Alzheimer\u2019s disease. J Neurol. 2007;254(3):391\u20133.","journal-title":"J Neurol"},{"key":"3_CR244","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2377-14-105","volume":"14","author":"YC Youn","year":"2014","unstructured":"Youn YC, Bagyinszky E, Kim H, Choi BO, An SS, Kim S. Probable novel PSEN2 Val214Leu mutation in Alzheimer\u2019s disease supported by structural prediction. BMC Neurol. 2014;14:105.","journal-title":"BMC Neurol."},{"issue":"5123","key":"3_CR245","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"E. Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;13;261(5123):921\u20133.","journal-title":"Science"},{"issue":"8873","key":"3_CR246","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","volume":"342","author":"J Poirier","year":"1993","unstructured":"Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer\u2019s disease. Lancet. 1993;342(8873):697\u20139.","journal-title":"Lancet"},{"issue":"4","key":"3_CR247","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron. 1993;11(4):575\u201380.","journal-title":"Neuron"},{"key":"3_CR248","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","volume":"47","author":"AD Roses","year":"1996","unstructured":"Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu Rev Med. 1996;47:387\u2013400.","journal-title":"Annu Rev Med"},{"issue":"8","key":"3_CR249","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology. 1993;43(8):1467\u201372.","journal-title":"Neurology"},{"issue":"9","key":"3_CR250","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jnen\/59.9.751","volume":"59","author":"AM Saunders","year":"2000","unstructured":"Saunders AM. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol. 2000;59(9):751\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"3_CR251","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"3_CR252","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archneur.65.12.1640","volume":"65","author":"KT Cuenco","year":"2008","unstructured":"Cuenco KT, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA, et al. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol. 2008;65(12):1640\u20138.","journal-title":"Arch Neurol"},{"issue":"2","key":"3_CR253","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/ahg.12000","volume":"77","author":"P Holton","year":"2013","unstructured":"Holton P, Ryten M, Nalls M, Trabzuni D, Weale ME, Hernandez D, et al. Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet. 2013;77(2):85\u2013105.","journal-title":"Ann Hum Genet"},{"issue":"4","key":"3_CR254","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s004390050234","volume":"98","author":"B Tycko","year":"1996","unstructured":"Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung WY, et al. Polymorphisms in the human apolipoproteinJ\/clusterin gene: ethnic variation and distribution in Alzheimer\u2019s disease. Hum Genet. 1996;98(4):430\u20136.","journal-title":"Hum Genet"},{"issue":"2","key":"3_CR255","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/alzrt71","volume":"3","author":"EH Kok","year":"2011","unstructured":"Kok EH, Luoto T, Haikonen S, Goebeler S, Haapasalo H, Karhunen PJ. CLU, CR255 and PICALM genes associate with Alzheimer\u2019s-related senile plaques. Alzheimers Res Ther. 2011;3(2):12.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"3_CR256","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, et al. Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet. 2008;83(5):623\u201332.","journal-title":"Am J Hum Genet"},{"issue":"33","key":"3_CR257","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S. CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 2013;33(33):13320\u20135.","journal-title":"J Neurosci"},{"key":"3_CR258","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.redox.2017.10.018","volume":"14","author":"SE Lacher","year":"2018","unstructured":"Lacher SE, Alazizi A, Wang X, Bell DA, Pique-Regi R, Luca F, Slattery M. A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer\u2019s disease. Redox Biol. 2018;14:686\u201393.","journal-title":"Redox Biol."},{"issue":"2","key":"3_CR259","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","volume":"78","author":"C Cruchaga","year":"2013","unstructured":"Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer\u2019s disease. Neuron. 2013;78(2):256\u201368.","journal-title":"Neuron"},{"issue":"21","key":"3_CR260","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, et al. Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet. 2014;23(21):5838\u201346.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3_CR261","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"3_CR262","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1001\/archgenpsychiatry.2010.196","volume":"68","author":"BM Schjeide","year":"2011","unstructured":"Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H, et al. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch Gen Psychiatry. 2011;68(2):207\u201313.","journal-title":"Arch Gen Psychiatry"},{"issue":"5 Suppl","key":"3_CR263","doi-asserted-by":"publisher","first-page":"S269","DOI":"10.1016\/j.jalz.2013.11.001","volume":"10","author":"K Morgen","year":"2014","unstructured":"Morgen K, Ramirez A, Fr\u00f6lich L, Tost H, Plichta MM, K\u00f6lsch H, et al. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(5 Suppl):S269\u201376.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3_CR264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-014-8834-2","volume":"52","author":"H Chen","year":"2015","unstructured":"Chen H, Wu G, Jiang Y, Feng R, Liao M, Zhang L, et al. Analyzing 54,936 samples supports the association between CD2AP rs9349407 polymorphism and Alzheimer\u2019s disease susceptibility. Mol Neurobiol. 2015;52(1):1\u20137.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3_CR265","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3233\/JAD-141488","volume":"44","author":"HF Wang","year":"2015","unstructured":"Wang HF, Tan L, Hao XK, Jiang T, Tan MS, Liu Y, et al. Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer\u2019s disease cohorts. J Alzheimers Dis. 2015;44(1):115\u201323.","journal-title":"J Alzheimers Dis"}],"container-title":["Advances in Experimental Medicine and Biology","Frontiers in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-32-9721-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T13:30:44Z","timestamp":1576071044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-32-9721-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789813297203","9789813297210"],"references-count":265,"URL":"https:\/\/doi.org\/10.1007\/978-981-32-9721-0_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"10 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}